Cooperative Agreement U52PS004641

This $550,000 Cooperative Agreement, awarded by the Centers for Disease Control and Prevention (CDC) under the Global Tuberculosis (TB) Federal Grant Program (CFDA 93.494), funds the Union Internationale Contre la Tuberculose et les Maladies Respiratoires (Uitmr) to collaborate on transforming evidence into practice to end the TB epidemic in resource-limited countries. The five-year award, spanning September 2024 to September 2029, supports Uitmr's efforts to develop and implement innovative...

This $212,636 Project Grant awarded by the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865) aims to develop tools to facilitate tuberculosis (TB) preventive therapy for children and adolescents in primary care settings in low- and middle-income countries. The key products or services to be delivered include: 1) deriving a risk score to predict chest X-ray abnormalities among child and adolescent...

This $178,443 Cooperative Agreement award from the National Center for HIV/AIDS, under the HIV Prevention Activities Health Department Based program (CFDA 93.940), supports the State of North Carolina Department of Health & Human Services (NC DHHS) in bolstering their tuberculosis (TB) prevention and control efforts. The award aims to quickly diagnose and treat TB disease, promptly investigate contacts of individuals with infectious TB, and efficiently streamline testing and treatment for...

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) is providing $766,877 to support a 5-year randomized controlled trial to evaluate the efficacy of therapeutic drug monitoring (TDM) in preventing premature discontinuation of the antibiotic linezolid in the treatment of rifampin-resistant tuberculosis (RR-TB). The study will enroll 280 participants with RR-TB in South Africa and randomize them...

This Project Grant award of $646,561 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports a study to evaluate the impact of a peer-navigation strategy on improving tuberculosis (TB) and HIV treatment adherence and outcomes among individuals in Uganda. The study aims to adapt and implement a multi-component peer-led TB education and adherence counseling intervention, and conduct a cluster-randomized trial to assess...

This Project Grant award from the John E. Fogarty International Center (CFDA 93.989 - International Research and Research Training) will provide $559,341 over 5 years to support research aimed at improving the diagnosis and treatment of tuberculosis (TB) in children under 5 years old in Malawi. The award recipient is a partnership between Henry Ford Health and Michigan State University Health Sciences, with Michigan State University serving as the parent organization. The key products and...

This Project Grant award of $209,750 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to leverage antibody-based "omics" approaches to prevent and detect tuberculosis (TB) in children affected by HIV. The key objectives are to: Define antibody Fc (fragment crystallizable) features associated with protection from Mycobacterium tuberculosis (MTB) infection in infants with and without...

The $3,595,735 Cooperative Agreement awarded by the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) federal grant program aims to reduce the burden of tuberculosis (TB), particularly drug-resistant TB, in the Central Asia region within five years. The award, granted to the Dutch non-profit organization Koninklijke Nederlandse Centrale Vereniging Tot Bestrijding DER Tuberculose (Kncv), will support technical expertise,...

This is a Cooperative Agreement awarded by the Centers for Disease Control and Prevention (CDC) under the Project Grants and Cooperative Agreements for Tuberculosis Control Programs (CFDA 93.116). The award of $210,141 will support the Puerto Rico Department of Health's efforts to control and eventually eliminate tuberculosis (TB) in Puerto Rico and the U.S. Virgin Islands. Key activities include enhancing TB surveillance, program planning and evaluation, providing consultation services to...

This federal Cooperative Agreement award from the National Center for HIV/AIDS (part of the Centers for Disease Control and Prevention) provides $785,722 in funding for the Indiana Department of Health's Tuberculosis (TB) Control Program under the HIV Prevention Activities Health Department Based program (CFDA 93.940). The purpose of this 5-year award, spanning January 1, 2025 to December 31, 2029, is to assist Indiana in addressing the strategies and implementing the activities identified to...